A detailed history of Deka Bank Deutsche Girozentrale transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 50,000 shares of DCPH stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$0
Previous $755,000 0.53%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$10.11 - $16.54 $505,500 - $827,000
50,000 New
50,000 $818,000
Q3 2021

Oct 22, 2021

SELL
$26.46 - $37.15 $433,944 - $609,260
-16,400 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$32.73 - $47.95 $654,599 - $959,000
-20,000 Reduced 54.95%
16,400 $591,000
Q4 2020

Mar 12, 2021

SELL
$51.77 - $66.18 $93,186 - $119,124
-1,800 Reduced 4.71%
36,400 $1.99 Million
Q3 2020

Oct 29, 2020

BUY
$43.8 - $58.16 $1.67 Million - $2.22 Million
38,200 New
38,200 $1.86 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.